What is the licensed dose for IV L-Ornithine L-Aspartate for hepatic encephalopathy?
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901070923431936 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The licensed dose for intravenous L-ornithine L-aspartate in hepatic encephalopathy is typically 30 g over 24 hours as a continuous infusion for a period of 5 days. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18812567 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the licensed dose for IV L-Ornithine L-Aspartate for hepatic encephalopathy? Tripdatabase L-Ornithine L-Aspartate hepatic encephalopathy IV dose licensed dose Gastroenterology Pharmacology liver disease treatment intravenous administration The licensed dose for intravenous L-ornithine L-aspartate in hepatic encephalopathy is typically 30 g over 24 hours as a continuous infusion for a period of 5 days. |
| title | What is the licensed dose for IV L-Ornithine L-Aspartate for hepatic encephalopathy? |
| topic | L-Ornithine L-Aspartate hepatic encephalopathy IV dose licensed dose Gastroenterology Pharmacology liver disease treatment intravenous administration |
| url | https://doi.org/10.5281/zenodo.18812567 |